Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on visible light catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel visible light catalysis method for indol-3-one derivatives. Offers mild conditions and high yield for scalable pharmaceutical intermediate manufacturing supply chains.
Patent CN105949079A enables green synthesis of pharmaceutical intermediates. Visible light catalysis ensures high purity and supply chain reliability for global buyers.
Patent CN110698369B reveals a mild visible-light method for synthesizing arylacetylene alkyl sulfones using alkyl fluoroborates, offering significant cost and safety advantages for pharmaceutical intermediate manufacturing.
Patent CN115745822A enables green visible light synthesis of N-formyl amides using copper catalysis, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN106467481A enables green synthesis of indole-3-aryl ketones. Visible light catalysis reduces costs and ensures reliable pharmaceutical intermediates supplier continuity.
Patent CN113754631B reveals a mild, regioselective method for heteroaryl indoles using visible light, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN113956208A reveals a metal-free, Eosin Y-catalyzed arylation method offering cost reduction in pharmaceutical intermediate manufacturing and scalable green chemistry solutions.
Patent CN108117507B details a green visible-light method for azaspirocyclohexadienone synthesis, offering cost reduction in pharmaceutical intermediate manufacturing and high purity.
Novel nickel-photocatalyzed method for (R)-1,3-diarylbutene offers mild conditions and high enantioselectivity, ensuring cost-effective supply chain solutions for pharmaceutical intermediates.
Novel photocatalytic synthesis of chiral alpha,alpha-diaryl ketones overcomes racemization. Ideal for API intermediates. Cost-effective scale-up and reliable supply.
Patent CN118344244A enables visible light catalyzed deuteration using D2O. Offers cost reduction and scalable supply for high-purity pharmaceutical intermediates.
Patent CN108947880B reveals a metal-free visible light method for thiocarbamates. Eliminate toxic phosgene, reduce costs, and ensure supply continuity with our advanced green chemistry solutions.
Novel visible light method reduces metal waste. Enhances supply chain stability for high-purity pharmaceutical intermediates. Cost-effective scalable production.
Patent CN107417566A enables ligand-free N-aryl hydrazone synthesis using BODIPY photocatalysts. Offers cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel visible-light method for iodo-bicyclo[1.1.1]pentane derivatives. Cost-effective, catalyst-free process ensuring high purity and supply chain reliability for pharmaceutical intermediates.
Patent CN115448816A reveals a mild, visible-light driven route for beta-fluoroalkenyl alcohols, offering safer manufacturing and cost reduction for pharma intermediates.
Patent CN116178254B reveals metal-free photocatalytic route for 2-trifluoromethylquinoline. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates globally.
Patent CN116462636B reveals green visible light synthesis for quinoxalinone derivatives. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN112321553A reveals a catalyst-free visible light method for 3-difluoromethyl coumarins, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN112194608A details a visible-light promoted synthesis method offering high yields and mild conditions for pharmaceutical intermediates.